FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

15972411000001107: Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56529001000001113 Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110030801000001117 Glucosamine sulfate 500mg / Chondroitin 400mg tablets (Zanza Specials International Ltd) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Is a Glucosamine sulphate 500mg / Chondroitin 400mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has AMP Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has specific active ingredient Chondroitin sulfate true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has specific active ingredient Glucosamine sulphate false Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Legal category Legal category not applicable true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Glucosamine sulphate 500mg / Chondroitin 400mg tablets (Zanza Laboratories Ltd) 30 tablet Has specific active ingredient Glucosamine sulfate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start